厂商 ：东莞康润仪器设备有限公司
广东 东莞- 主营产品：
- 玻璃器皿
- 样品前处理装置
- 标准物质
联系电话 ：13925770466
商品详细描述
| MM0077.00 | 盐酸丙咪嗪 | 500mg | 12953 | Imipramine Hydrochloride | 含量测定 |
| MM0077.05 | 盐酸丙咪嗪杂质B | 100mg | 12953 | Imipramine Hydrochloride Imp. B (EP): 3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine (Depramine; 10,11-Dehydroimipramine) | 含量测定 |
| MM0077.08 | 盐酸丙咪嗪杂质C | 100mg | 12953 | Imipramine Hydrochloride Imp. C (EP) as Hydrochloride: 10-[3-(Dimethyl-amino)propyl]acridin-9(10H)-one Hydrochloride | 含量测定 |
| MM0077.12 | 丙咪嗪氮氧化物 | 100mg | 12953 | Imipramine N-Oxide | 含量测定 |
| MM0078.00 | 硝西泮 | 100mg | 12953 | Nitrazepam [Controlled Substance] | 含量测定 |
| MM0078.01 | 硝西泮杂质B | 100mg | 4950 | Nitrazepam Imp. B (EP): (2-Amino-5-nitrophenyl)phenylmethanone (2-Amino-5-nitrobenzophenone) | 含量测定 |
| MM0078.02 | 硝西泮杂质A | 100mg | 12953 | Nitrazepam Imp. A (EP): 3-Amino-6-nitro-4-phenylquinolin-2(1H)-one | 含量测定 |
| MM0078.07 | 7-氨基硝西泮 | 100mg | 12953 | 7-Aminonitrazepam | 含量测定 |
| MM0079.00 | 盐酸去甲替林 | 500mg | 12953 | Nortriptyline Hydrochloride | 含量测定 |
| MM0080.00 | 奥沙西泮 | 100mg | 26235 | Oxazepam [Controlled Substance] | 含量测定 |
| MM0081.00 | 盐酸去氧肾上腺素 | 500mg | 12953 | Phenylephrine Hydrochloride | 含量测定 |
| MM0082.00 | 氧烯洛尔 | 250mg | 12953 | Pindolol | 含量测定 |
| MM0082.01 | 氧烯洛尔杂质E | 100mg | 12953 | Pindolol Imp. E (EP): 1H-Indol-4-ol | 含量测定 |
| MM0082.02 | 氧烯洛尔杂质D | 100mg | 12953 | Pindolol Imp. D (EP): (2RS)-3-(1H-Indol-4-yloxy)propane-1,2-diol | 含量测定 |
| MM0082.06 | 氧烯洛尔杂质C | 100mg | 12953 | Pindolol Imp. C (EP): 1,1-[(1-Methylethyl)imino]bis[3-(1H-indol-4-yloxy)propan-2-ol] | 含量测定 |
| MM0082.08 | 氧烯洛尔杂质B | 100mg | 26235 | Pindolol Imp. B (EP): 1-[4-[2-Hydroxy-3-[(1-methyl-ethyl)amino]propoxy]-1H-indol-1-yl]-3-[(1-methylethyl)amino]propan-2-ol | 含量测定 |
| MM0083.00 | 吡拉西坦 | 500mg | 12953 | Piracetam | 含量测定 |
| MM0083.01 | 吡拉西坦杂质D | 100mg | 12953 | Piracetam Imp. D (EP): (2-Oxopyrrolidin-1-yl)acetic Acid | 含量测定 |
| MM0083.02 | 吡拉西坦杂质C | 100mg | 12953 | Piracetam Imp. C (EP): Ethyl (2-Oxopyrrolidin-1-yl)acetate | 含量测定 |
| MM0083.04 | 吡拉西坦杂质B | 100mg | 12953 | Piracetam Imp. B (EP): Methyl (2-Oxopyrrolidin-1-yl)acetate | 含量测定 |
| MM0083.06 | 2-氯乙酰氨 | 100mg | 6105 | 2-Chloroacetamide | 含量测定 |
| MM0084.00 | 吡罗昔康 | 500mg | 12953 | Piroxicam | 含量测定 |
| MM0084.01 | 2-对氨基氮苯 | 100mg | 4950 | Pyridin-2-amine(2-Pyridylamine) | 含量测定 |
| MM0084.04 | 吡罗昔康杂质G | 100mg | 12953 | Piroxicam Imp. G (EP): Methyl 4-Hydroxy- 2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide | 含量测定 |
| MM0084.05 | 吡罗昔康杂质E | 100mg | 12953 | Piroxicam Imp. E (EP): Ethyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate | 含量测定 |
| MM0084.06 | 吡罗昔康杂质H | 100mg | 12953 | Piroxicam Imp. H (EP): Ethyl 4-Hydroxy- 2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide | 含量测定 |
| MM0084.07 | 吡罗昔康杂质D | 100mg | 12953 | Piroxicam Imp. D (EP): Methyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate | 含量测定 |
| MM0084.08 | 吡罗昔康杂质B | 100mg | 12953 | Piroxicam Imp. B (EP): 4-Hydroxy-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide1,1-Dioxide | 含量测定 |
| MM0084.09 | 吡罗昔康杂质C | 100mg | 12953 | Piroxicam Imp. C (EP): 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide1,1-Dioxide | 含量测定 |
| MM0084.10 | 吡罗昔康杂质F | 100mg | 12953 | Piroxicam Imp. F (EP): 1-Methylethyl (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetate | 含量测定 |
| MM0084.11 | 吡罗昔康杂质I | 100mg | 12953 | Piroxicam Imp. I (EP): 1-Methylethyl 4-Hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide | 含量测定 |
| MM0085.00 | 盐酸哌唑嗪 | 100mg | 12953 | Prazosin Hydrochloride | 含量测定 |
| MM0085.01 | 盐酸哌唑嗪杂质C | 100mg | 12953 | Prazosin Hydrochloride Imp. C (EP): 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine | 含量测定 |
| MM0085.02 | 盐酸哌唑嗪杂质D | 100mg | 12953 | Prazosin Hydrochloride Imp. D (EP): 1-(Furan-2-ylcarbonyl)piperazine | 含量测定 |
| MM0085.03 | 盐酸哌唑嗪杂质E | 100mg | 26235 | Prazosin Hydrochloride Imp. E (EP): 2,2-(Piperazin-1,4-diyl)bis-(6,7-dimethoxyquinazolin-4-amine) | 含量测定 |
| MM0086.00 | 雷尼替丁盐酸盐 | 500mg | 12953 | Ranitidine Hydrochloride | 含量测定 |
| MM0086.01 | 雷尼替丁盐酸盐杂质B | 100mg | 12953 | Ranitidine Hydrochloride Imp. B (EP): 2-[[[5-[(Dimethylamino)methyl]-furan-2-yl]methyl]sulphanyl]ethanamine | 含量测定 |
| MM0086.02 | 雷尼替丁盐酸盐杂质A | 100mg | 12953 | Ranitidine Hydrochloride Imp. A (EP): N,N-Bis[2-[[[5-[(dimethylamino)methyl]furan-2-yl]-methyl]sulphanyl]ethyl]-2-nitroethene-1,1-diamine | 含量测定 |
| MM0086.03 | 雷尼替丁盐酸盐杂质C | 100mg | 12953 | Ranitidine Hydrochloride Imp. C (EP): N-[2-[[[5-[(Dimethylamino)-methyl]furan-2-yl]methyl]sulphinyl]ethyl]-N-methyl-2-nitroethene-1,1-diamine(Ranitidine Sulphoxide) | 含量测定 |
| MM0086.05 | 雷尼替丁盐酸盐杂质E | 100mg | 26235 | Ranitidine Hydrochloride Imp. E (EP): N-[2-[[[5-[(Dimethyloxidoamino)-methyl]furan-2-yl]methyl]sulphanyl]ethyl]-N-methyl-2-nitroethene-1,1-diamine (Ranitidine N-Oxide) | 含量测定 |
| MM0086.06 | 雷尼替丁盐酸盐杂质D | 100mg | 12953 | Ranitidine Hydrochloride Imp. D (EP) as Sodium Salt: N-[2-[[[5-[(Dimethylamino)methyl]furan-2-yl]-methyl]sulphanyl]ethyl]-2-nitroacetamide Sodium Salt | 含量测定 |
| MM0086.08 | 雷尼替丁盐酸盐杂质H | 100mg | 12953 | Ranitidine Hydrochloride Imp. H (EP): N-Methyl-2-nitroacetamide | 含量测定 |
| MM0086.10 | 雷尼替丁盐酸盐杂质I | 100mg | 12953 | Ranitidine Hydrochloride Imp. I (EP): | 含量测定 |
| MM0086.17 | 雷尼替丁盐酸盐杂质F | 100mg | 12953 | Ranitidine Hydrochloride Imp. F (EP) as Hydrochloride: [5-[(Dimethyl-amino)methyl]furan-2-yl]methanol Hydrochloride | 含量测定 |
| MM0087.00 | 替马西泮 | 100mg | 12953 | Temazepam [Controlled Substance] | 含量测定 |
| MM0088.00 | 盐酸四氢唑啉 | 100mg | 12953 | Tetryzoline Hydrochloride | 含量测定 |
| MM0088.03 | 盐酸四氢唑啉杂质A | 100mg | 12953 | Tetryzoline Hydrochloride Imp. A (EP): (1RS)-1,2,3,4-Tetrahydronaphthalene-1-carbonitrile (a-Cyanotetraline) | 含量测定 |
| MM0089.00 | 盐酸赛洛唑啉 | 500mg | 12953 | Xylometazoline Hydrochloride | 含量测定 |
| MM0089.02 | 盐酸赛洛唑啉杂质F | 100mg | 12953 | Xylometazoline Hydrochloride Imp. F (Pharmeuropa): [4-(1,1-Dimethylethyl)-2,6-dimethylphenyl]acetic Acid | 含量测定 |
| MM0089.03 | 盐酸赛洛唑啉杂质C | 100mg | 12953 | Xylometazoline Hydrochloride Imp. C (EP): [4-(1,1-Dimethylethyl)-2,6-dimethylphenyl]acetonitrile | 含量测定 |
| MM0089.04 | 盐酸赛洛唑啉杂质B | 100mg | 12953 | Xylometazoline Hydrochloride Imp. B (EP): 2-(Chloromethyl)-5-(1,1-dimethylethyl)-1,3-dimethylbenzene | 含量测定 |
| MM0089.05 | 盐酸赛洛唑啉杂质D | 100mg | 6105 | Xylometazoline Hydrochloride Imp. D (EP): 1-(1,1-Dimethylethyl)-3,5-dimethylbenzene | 含量测定 |
| MM0089.07 | 盐酸赛洛唑啉杂质A | 100mg | 12953 | Xylometazoline HCL Imp. A (EP) as Hydrochloride: N-(2-Aminoethyl)-2-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]acetamide Hydrochloride | 含量测定 |
| MM0090.00 | 氯苯那敏马来酸盐 | 500mg | 12953 | Chlorphenamine Maleate | 含量测定 |
| MM0090.03 | 氯苯那敏马来酸盐杂质A | 100mg | 26235 | Chlorphenamine Maleate Imp. A (EP) as Dihydrochloride: 2-(4-Chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)ethyl]butanenitrile Dihydrochloride | 含量测定 |
| MM0090.04 | 氯苯那敏马来酸盐杂质B | 100mg | 12953 | Chlorphenamine Maleate Imp. B (EP): N-(Pyridin-2-yl)pyridin-2-amine(2,2-Dipyridylamine) | 含量测定 |
| MM0090.05 | 氯苯那敏马来酸盐杂质D | 100mg | 26235 | Chlorphenamine Maleate Imp. D (EP) as Maleate: (2RS)-2-(4-Chloro-phenyl)-4-(dimethylamino)-2-(pyridin-2-yl)butanenitrile Maleate | 含量测定 |
| MM0090.11 | 氯苯那敏氮氧化物二盐酸盐 | 100mg | 12953 | Chlorphenamine N-Oxide Dihydrochloride | 含量测定 |
| MM0090.13 | 氯苯那敏马来酸盐杂质C | 100mg | 12953 | Chlorphenamine Maleate Imp. C (EP) as Maleate: (3RS)-3-(4-Chloro-phenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine Maleate | 含量测定 |
| MM0091.00 | 四氢西泮 | 100mg | 12953 | Tetrazepam [Controlled Substance] | 含量测定 |
| MM0091.06 | 四氢西泮杂质B | 100mg | 12953 | Tetrazepam Imp. B (EP): 7-Chloro-5-cyclohexyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 含量测定 |
| MM0091.07 | 四氢西泮杂质C | 100mg | 12953 | Tetrazepam Imp. C (EP): 7-Chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 含量测定 |
| MM0092.00 | 尼群地平 | 500mg | 12953 | Nitrendipine | 含量测定 |
| MM0092.01 | 尼群地平杂质B | 100mg | 12953 | Nitrendipine Imp. B (EP): Dimethyl 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 含量测定 |
| MM0092.02 | 尼群地平杂质C | 100mg | 12953 | Nitrendipine Imp. C (EP): Diethyl 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 含量测定 |
| MM0092.03 | 尼群地平杂质A | 100mg | 12953 | Nitrendipine Imp. A (EP): Ethyl Methyl 2,6-Dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate(Photolysis Product) | 含量测定 |
| MM0093.00 | 甲氧苄啶 | 500mg | 12953 | Trimethoprim | 含量测定 |
| MM0093.01 | 甲氧苄啶杂质B | 100mg | 12953 | Trimethoprim Imp. B (EP): (2,4-Diaminopyrimidin-5-yl)- (3,4,5-trimethoxyphenyl)methanone | 含量测定 |
| MM0093.03 | 甲氧苄啶杂质E | 100mg | 12953 | Trimethoprim Imp. E (EP): 4-Amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol | 含量测定 |
| MM0093.04 | 甲氧苄啶杂质D | 100mg | 12953 | Trimethoprim Imp. D (EP): 2-Amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-4-ol | 含量测定 |
| MM0093.06 | 甲氧苄啶杂质A | 100mg | 12953 | Trimethoprim Imp. A (EP): N2-Methyl-5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine | 含量测定 |
| MM0093.08 | 甲氧苄啶杂质C | 100mg | 12953 | Trimethoprim Imp. C (EP): (RS)-(2,4-Diaminopyrimidin-5-yl) (3,4,5-trimethoxyphenyl)methanol | 含量测定 |
| MM0093.09 | 甲氧苄啶杂质F | 100mg | 12953 | Trimethoprim Imp. F (EP): 5-(3-Bromo-4,5-dimethoxybenzyl)pyrimidine-2,4-diamine | 含量测定 |
| MM0093.10 | 甲氧苄啶杂质G | 100mg | 12953 | Trimethoprim Imp. G (EP): 5-(4-Ethoxy-3,5-dimethoxybenzyl)pyrimidine-2,4-diamine | 含量测定 |
| MM0093.11 | 甲氧苄啶杂质H | 100mg | 12953 | Trimethoprim Imp. H (EP): Methyl 3,4,5-Trimethoxybenzoate | 含量测定 |
| MM0093.12 | 甲氧苄啶杂质I | 100mg | 12953 | Trimethoprim Imp. I (EP): 3-(Phenylamino)-2-(3,4,5-trimethoxybenzyl)prop-2-enenitrile (E/Z-mixture) | 含量测定 |
| MM0093.13 | 3,4,5-三甲氧基苯甲酸 | 100mg | 4950 | 3,4,5-Trimethoxybenzoic Acid | 含量测定 |
| MM0093.17 | 盐酸苯胺 | 100mg | 4950 | Aniline Hydrochloride | 含量测定 |
| MM0094.00 | 苯佐卡因 | 500mg | 12953 | Benzocaine | 含量测定 |
| MM0094.01 | 苯佐卡因乙酰基水杨酰胺 | 50mg | 6105 | Benzocaine Acetylsalicylamide | 含量测定 |
| MM0094.02 | N-乙酰苯佐卡因 | 100mg | 12953 | N-Acetylbenzocaine | 含量测定 |
| MM0094.03 | 4-氨基苯酸 | 100mg | 4950 | 4-Aminobenzoic Acid | 含量测定 |
| MM0094.04 | 硝基苯甲酸乙酯 | 100mg | 4950 | Ethyl 4-Nitrobenzoate | 含量测定 |
| MM0095.00 | 奥美拉唑 | 500mg | 12953 | Omeprazole | 含量测定 |
| MM0095.01 | 奥美拉唑杂质F | 50mg | 26235 | Omeprazole Imp. F (EP): 8-Methoxy-1,3-dimethyl-12-thioxopyrido[1,2:3,4]imidazo[1,2-a]-benzimidazol-2(12H)-one | 含量测定 |
| MM0095.02 | 奥美拉唑杂质G | 50mg | 26235 | Omeprazole Imp. G (EP): 9-Methoxy-1,3-dimethyl-12-thioxopyrido[1,2:3,4]imidazo[1,2-a]-benzimidazol-2(12H)-one | 含量测定 |
| MM0095.15 | 奥美拉唑杂质H | 100mg | 26235 | Omeprazole Imp. H (EP): 2-[(RS)-[(4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole | 含量测定 |
| MM0095.16 | 奥美拉唑杂质I | 100mg | 12953 | Omeprazole Imp. I (EP): 4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulphonyl]methyl]-3,5-dimethylpyridine 1-Oxide(Omeprazole Sulphone N-Oxide) | 含量测定 |
| MM0098.00 | 右丙氧酚 | 50mg | 12953 | Dextropropoxyphene [Controlled Substance] | 含量测定 |
| MM0098.01 | 右丙氧酚盐酸盐 | 50mg | 12953 | Dextropropoxyphene HCl Controlled Substance | 含量测定 |
| MM0098.06 | 右丙氧酚盐酸盐杂质A | 100mg | 12953 | Dextropropoxyphene Hydrochloride Imp. A (EP):(2S,3R)-4-(Dimethylamino)-1,2-diphenyl-3-methylbutan-2-ol | 含量测定 |
| MM0098.07 | 右丙氧酚盐酸盐杂质B | 100mg | 12953 | Dextropropoxyphene Imp. B (EP) as Hydrochloride: (1S,2R)-1-Benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl Acetate Hydrochloride(Acetoxyphene Hydrochloride) | 含量测定 |
| MM0099.00 | 泮托拉唑钠 | 100mg | 26235 | Pantoprazole Sodium | 含量测定 |
| MM0099.01 | 泮托拉唑 | 100mg | 26235 | Pantoprazole | 含量测定 |
| MM0099.02 | 泮托拉唑钠半水合物杂质A | 100mg | 12953 | Pantoprazole Sodium Sesquihydrate Imp. A (EP): 5-(Difluoromethoxy)-2-[[(3,4-dimethoxypyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole (Pantoprazole Sulphone) | 含量测定 |
| MM0099.03 | 泮托拉唑钠半水合物杂质B | 100mg | 12953 | Pantoprazole Sodium Sesquihydrate Imp. B (EP): 5-(Difluoromethoxy)-2-[[(3,4-dimethoxypyridin-2-yl)methyl]sulphanyl]-1H-benzimidazole | 含量测定 |
| MM0099.04 | 泮托拉唑钠半水合物杂质C | 100mg | 12953 | Pantoprazole Sodium Sesquihydrate Imp. C (EP): 5-(Difluoromethoxy)-1H-benzimidazole-2-thiol | 含量测定 |
| MM0099.05 | 泮托拉唑钠 | 100mg | 12953 | 2-Chloromethyl-3,4-dimethoxypyridine Hydrochloride | 含量测定 |
| MM0099.06 | 泮托拉唑钠氮氧化物 | 100mg | 26235 | Pantoprazole N-Oxide | 含量测定 |
| MM0099.07 | 泮托拉唑钠砜氮氧化物 | 100mg | 12953 | Pantoprazole Sulphone N-Oxide | 含量测定 |
| MM0099.11 | 泮托拉唑钠半水合物杂质D | 100mg | 26235 | Pantoprazole Sodium Sesquihydrate Mixture of Imp. D and F (EP): 5- and 6-(Di-fluoromethoxy)-2-[(RS)-[(3,4-dimethoxypyridin-2-yl)methyl]sulphinyl]-1-methyl-1H-benzimidazole | 含量测定 |
| MM0100.01 | 雌莫司汀 | 100mg | 26235 | Estramustine | 含量测定 |
| MM0101.00 | 琥珀酸多西拉敏 | 500mg | 12953 | Doxylamine Hydrogen Succinate | 含量测定 |
| MM0101.02 | 琥珀酸多西拉敏杂质B | 50mg | 12953 | Doxylamine Hydrogen Succinate Imp. B (EP) as Hydrochloride: (1RS)-1-Phenyl-1-(pyridin-2-yl)ethanol Hydrochloride | 含量测定 |
| MM0101.03 | 琥珀酸多西拉敏杂质C | 50mg | 12953 | Doxylamine Hydrogen Succinate Imp. C (EP) as Hydrogen Fumarate: N,N-Dimethyl-2-[(RS)-1-phenyl(pyridin-2-yl)-methoxy]ethanamine Hydrogen Fumarate | 含量测定 |
| MM0101.04 | 琥珀酸多西拉敏杂质D | 100mg | 12953 | Doxylamine Hydrogen Succinate Imp. D (EP): Phenyl(pyridin-2-yl)methanone(2-Benzoylpyridine) | 含量测定 |
| MM0101.05 | 多西拉敏氮氧化物二盐酸盐 | 100mg | 12953 | Doxylamine N-Oxide Dihydrochloride | 含量测定 |
| MM0101.08 | N-去甲基多西拉敏琥珀酸氢盐 | 50mg | 12953 | N-Desmethyldoxylamine Hydrogen Succinate | 含量测定 |
| MM0102.00 | 利多卡因 | 500mg | 12953 | Lidocaine | 含量测定 |
| MM0102.01 | 利多卡因盐酸盐杂质B | 100mg | 12953 | Lidocaine Hydrochloride Imp. B (EP): 2-(Diethylazinoyl)-N-(2,6-dimethylphenyl)acetamide (Lidocaine N2-Oxide) | 含量测定 |
| MM0102.02 | 2，6-二甲基苯胺 | 100mg | 4950 | 2,6-Dimethylaniline | 含量测定 |
| MM0102.03 | 利多卡因盐酸盐杂质H | 100mg | 4950 | Lidocaine Hydrochloride Imp. H (EP): 2-Chloro-N-(2,6-dimethylphenyl)-acetamide | 含量测定 |
| MM0102.04 | 利多卡因盐酸盐单水合物 | 500mg | 12953 | Lidocaine Hydrochloride Monohydrate | 含量测定 |
| MM0102.05 | 利多卡因盐酸盐杂质D | 100mg | 12953 | Lidocaine Hydrochloride Imp. D (EP) as Hydrochloride: N-(2,6-Dimethylphenyl)-2-(ethylamino)acetamide Hydrochloride (Monoethylglycinexylidide Hydrochloride) | 含量测定 |
| MM0102.09 | 利多卡因盐酸盐杂质E | 100mg | 12953 | Lidocaine Hydrochloride Imp. E (EP) as Hydrochloride: 2,2-(Azanediyl)bis[N-(2,6-dimethylphenyl)-acetamide] Hydrochloride | 含量测定 |
| MM0102.10 | 利多卡因盐酸盐杂质F | 100mg | 12953 | Lidocaine Hydrochloride Imp. F (EP) as Hydrochloride: 2-(Diethyl-amino)-N-(2,3-dimethylphenyl)acetamide Hydrochloride | 含量测定 |
| MM0102.11 | 利多卡因盐酸盐杂质G | 100mg | 12953 | Lidocaine Hydrochloride Imp. G (EP) as Hydrochloride: N-(2,6-Dimethylphenyl)-2-[(1-methylethyl)amino]-acetamide Hydrochloride | 含量测定 |
| MM0102.14 | 利多卡因盐酸盐杂质K | 100mg | 12953 | Lidocaine Hydrochloride Imp. K (EP) as Hydrochloride: N-(2,6-Dimethyl-phenyl)-2-(ethylmethylamino)acetamide Hydro-chloride | 含量测定 |
| MM0104.00 | 烟酸苄酯 | 500mg | 12953 | Benzyl Nicotinate | 含量测定 |
| MM0105.02 | 依托芬那酯杂质B | 100mg | 12953 | Etofenamate Imp. B (EP): Butyl 2-[[3-(Trifluoromethyl)phenyl]amino benzoate (Butyl Flufenamate) | 含量测定 |
| MM0105.03 | 依托芬那酯杂质C | 100mg | 12953 | Etofenamate Imp. C (EP): N-Phenyl-3-(trifluoromethyl)aniline | 含量测定 |
| MM0105.04 | 依托芬那酯杂质D | 100mg | 12953 | Etofenamate Imp. D (EP): 2,2-Oxybis(ethylene) Bis [2-[[3-(trifluoromethyl)-phenyl]amino]benzoate] | 含量测定 |
| MM0105.05 | 依托芬那酯杂质E | 100mg | 12953 | Etofenamate Imp. E (EP): 2-(2-Butoxyethoxy)ethyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate | 含量测定 |
| MM0105.06 | 2,2-氧代二乙醇 | 100mg | 12953 | 2,2-Oxydiethanol | 含量测定 |
| MM0105.07 | 依托芬那酯杂质G | 100mg | 12953 | Etofenamate Imp. G (EP): 2-Hydroxyethyl 2-[[3-(Trifluoro-methyl)phenyl]amino]benzoate | 含量测定 |
| MM0105.08 | 依托芬那酯十四酸盐 | 100mg | 12953 | Etofenamate Myristate | 含量测定 |
| MM0105.09 | 依托芬那酯棕榈酸酯 | 100mg | 12953 | Etofenamate Palmitate | 含量测定 |
| MM0105.10 | 依托芬那酯硬脂酸盐 | 100mg | 12953 | Etofenamate Stearate | 含量测定 |
| MM0105.11 | 三甘醇依托芬那酯 | 100mg | 12953 | Triethylene Glycol Flufenamate | 含量测定 |
| MM0107.00 | 多潘立酮 | 100mg | 26235 | Domperidone | 含量测定 |
| MM0107.03 | 多潘立酮杂质F | 50mg | 12953 | Domperidone Imp. F (EP): 1,3-Bis[3-[4-(5-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]propyl]-1,3-dihydro-2H-benzimidazol-2-one | 含量测定 |
| MM0107.05 | 多潘立酮杂质B | 100mg | 12953 | Domperidone Imp. B (EP): 4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-formylpiperidine | 含量测定 |
| MM0107.06 | 多潘立酮杂质A | 100mg | 12953 | Domperidone Imp. A (EP): 5-Chloro-1-(piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one | 含量测定 |
| MM0108.00 | 丙吡胺 | 500mg | 12953 | Disopyramide | 含量测定 |
| MM0109.03 | 芦丁芸香苷三水合物杂质C | 100mg | 12953 | Rutoside Trihydrate Imp. C (EP) as Dihydrate: 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Dihydrate (Quercetin Dihydrate) | 含量测定 |
| MM0111.00 | 己雷琐辛 | 500mg | 12953 | Hexylresorcinol | 含量测定 |
| MM0112.00 | 水杨酸羟乙酯 | 500mg | 12953 | Hydroxyethyl Salicylate | 含量测定 |
| MM0113.00 | 苯哌利多 | 100mg | 12953 | Benperidol | 含量测定 |
| MM0113.03 | 苯哌利多杂质A | 100mg | 12953 | Benperidol Imp. A (EP): 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one | 含量测定 |
| MM0114.00 | 氟奋乃静双盐酸盐 | 500mg | 12953 | Fluphenazine Dihydrochloride | 含量测定 |
| MM0114.01 | 氟奋乃静双盐酸盐杂质A | 100mg | 12953 | Fluphenazine Hydrochloride Imp. A (EP): 2-[4-[3-[5-Oxo-2-(trifluoromethyl)-10H-54-phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol (Fluphenazine S-Oxide) | 含量测定 |
| MM0114.07 | 氟奋乃静双盐酸盐杂质D | 100mg | 12953 | Fluphenazine Hydrochloride Imp. D (EP): 10,10-[Piperazine-1,4-diylbis(propane-3,1-diyl)]bis[2-(trifluoromethyl)-10H-phenothiazine] | 含量测定 |
| MM0115.00 | 尼麦角林 | 100mg | 12953 | Nicergoline | 含量测定 |
| MM0115.02 | 尼麦角林杂质A | 50mg | 26235 | Nicergoline Imp. A (EP): [(6aR,9R,10aS)-10a-Methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinolin-9-yl]methyl 5-Chloro-pyridine-3-carboxylate | 含量测定 |
| MM0115.03 | 5-脱溴尼麦角林 | unit | 26235 | 5-Debromonicergoline | 含量测定 |
| MM0115.04 | 尼麦角林杂质C | 100mg | 26235 | Nicergoline Imp. C (EP): [(6aR,9R,10aS)-10a-Methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]methanol(Methylmethoxylumilysergol) | 含量测定 |
| MM0115.06 | 尼麦角林杂质D | 100mg | 4950 | Nicergoline Imp. D (EP): 5-Bromopyridine-3-carboxylic Acid | 含量测定 |
| MM0116.05 | 2-甲巯基吩噻嗪 | 100mg | 12953 | 2-Methylthiophenothiazine | 含量测定 |
| MM0119.00 | 塞克硝唑 | 100mg | 12953 | Secnidazole | 含量测定 |
| MM0120.00 | 丁丙诺啡 | 100mg | 12953 | Buprenorphine [Controlled Substance] | 含量测定 |
| MM0121.00 | 左炔诺孕酮 | 250mg | 12953 | Levonorgestrel | 含量测定 |
| MM0123.00 | 炔雌醇 | 500mg | 12953 | Ethinylestradiol | 含量测定 |
| MM0123.02 | 炔雌醇杂质B | 50mg | 26235 | Ethinylestradiol Imp. B (EP): 19-Nor-17a-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol (9,11-Didehydroethinylestradiol) | 含量测定 |
| MM0123.05 | 炔雌醇杂质G | 100mg | 26235 | Ethinylestradiol Imp. G (Pharmeuropa): 3,17-Dihydroxy-19-nor-17a-pregna-1,3,5(10)-trien-20-yn-6-one (6-Oxoethinylestradiol, 6-Ketoethinylestradiol) | 含量测定 |
| MM0123.06 | 炔雌醇杂质F | 25mg | 26235 | Ethinylestradiol Imp. F (Pharmeuropa): 19-Nor-17a-pregna-1,3,5(10)-trien-20-yne-3,6b,17-triol(6b-Hydroxyethinylestradiol) | 含量测定 |
| MM0123.07 | 炔雌醇杂质E | 100mg | 26235 | Ethinylestradiol Imp. E (Pharmeuropa): 19-Nor-17a-pregna-1,3,5(10)-trien-20-yne-3,6a,17-triol (6a-Hydroxyethinylestradiol) | 含量测定 |
| MM0123.08 | 炔雌醇杂质I | 50mg | 26235 | Ethinylestradiol Imp. I (Pharmeuropa): 19-Nor-17a-pregna-1,3,5(10),6-tetraen-20-yne-3,17-diol(6,7-Didehydroethinylestradiol) | 含量测定 |
| MM0124.06 | 孕二烯酮杂质L | 100mg | 12953 | Gestodene Imp. L (EP): 13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregna-5,15-dien-20-yn-3-one (Delta5(6)-Gestodene) | 含量测定 |
| MM0125.01 | 盐酸美噻吨杂质A | 100mg | 12953 | Metixene Hydrochloride Imp. A (EP): 9H-Thioxanthene | 含量测定 |
| MM0125.02 | 盐酸美噻吨杂质B | 100mg | 4950 | Metixene HydrochlorideImp. B (EP): 9H-Thioxanthen-9-one(Thioxanthone) | 含量测定 |
| MM0126.02 | 异山梨醇二甲醚 | 100mg | 4950 | Dimethyl Isosorbide | 含量测定 |
| MM0126.03 | 异山梨酯 | 500mg | 12953 | Isosorbide | 含量测定 |
| MM0126.04 | 硝酸异山梨醇酯 | unit | 26235 | Isomannit Dinitrate | 含量测定 |
| MM0127.00 | 硫辛酸 | 500mg | 12953 | Thioctic Acid | 含量测定 |
| MM0128.00 | 盐酸塞利洛尔 | 100mg | 12953 | Celiprolol Hydrochloride | 含量测定 |
| MM0128.01 | 盐酸塞利洛尔杂质A | 100mg | 12953 | Celiprolol Hydrochloride Imp. A (EP): 1-[5-Amino-2-[(2RS)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]ethanone | 含量测定 |
| MM0128.03 | 盐酸塞利洛尔杂质C | 100mg | 12953 | Celiprolol Hydrochloride Imp. C (EP): 1-[3-Acetyl-4-[(2RS)-3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]-3-(1,1-dimethylethyl)urea | 含量测定 |
| MM0128.04 | 盐酸塞利洛尔杂质H | 100mg | 12953 | Celiprolol Hydrochloride Imp. H (EP): 3-[3-Acetyl-4-[(2RS)-3-bromo-2-hydroxypropoxy]phenyl]-1,1-diethylurea(Bromhydrin Compound), | 含量测定 |
| MM0128.05 | 盐酸塞利洛尔杂质E | 50mg | 26235 | Celiprolol Hydrochloride Imp. E (EP): 1,1-[[(1,1-Dimethylethyl)-imino]bis[(2-hydroxypropane-1,3-diyl)-oxy(3-acetyl-1,4-phenylene)]]bis(3,3-diethylurea) | 含量测定 |
| MM0128.06 | 盐酸塞利洛尔杂质G | 100mg | 12953 | Celiprolol Hydrochloride Imp. G (EP): 3-[3-Acetyl-4-[[(RS)-oxiranyl]methoxy]phenyl]-1,1-diethylurea | 含量测定 |
| MM0128.07 | 盐酸塞利洛尔杂质F | 100mg | 12953 | Celiprolol Hydrochloride Imp. F (EP): 3-(3-Acetyl-4-hydroxyphenyl)-1,1-diethylurea | 含量测定 |
| MM0128.10 | 盐酸塞利洛尔杂质D | 100mg | 26235 | Celiprolol Hydrochloride Imp. D (EP): 3-[3-Acetyl-4-[(RS)-3-(diethylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea | 含量测定 |
| MM0129.00 | 盐酸氧烯洛尔 | 500mg | 12953 | Oxprenolol Hydrochloride | 含量测定 |
| MM0130.00 | 雌三醇 | 100mg | 12953 | Estriol | 含量测定 |
| MM0130.01 | 雌三醇杂质C | 100mg | 26235 | Estriol Imp. C (EP): 3-Methoxyestra-1,3,5(10)-triene-16a,17b-diol (Estriol 3-Methyl Ether) | 含量测定 |
| MM0130.02 | 6α-羟基雌三醇 | 100mg | 26235 | 6a-Hydroxyestriol | 含量测定 |
| MM0130.03 | 雌三醇杂质G | 100mg | 26235 | Estriol Imp. G (EP): Estra-1,3,5(10)-triene-3,16b,17a-triol (16,17-epi-Estriol) | 含量测定 |
| MM0130.04 | 雌三醇杂质F | 100mg | 26235 | Estriol Imp. F (EP): Estra-1,3,5(10)-triene-3,16b,17b-triol (16-epi-Estriol) | 含量测定 |
| MM0130.05 | 雌三醇杂质E | 100mg | 26235 | Estriol Imp. E (EP): Estra-1,3,5(10)-triene-3,16a,17a-triol (17-epi-Estriol) | 含量测定 |
| MM0130.06 | 雌三醇杂质A | 100mg | 26235 | Estriol Imp. A (EP): Estra-1,3,5(10),9(11)-tetraene-3,16a,17b-triol (9,11-Didehydroestriol) | 含量测定 |
| MM0130.22 | 雌三醇杂质I | 100mg | 26235 | Estriol Imp. I (EP): 3-Hydroxy-17-oxa-D-homoestra-1,3,5(10)-trien-17a-one | 含量测定 |
| MM0131.02 | 土根碱二盐酸盐 | 100mg | 12953 | Emetine Dihydrochloride | 含量测定 |
| MM0132.10 | 红霉素杂质E | 50mg | 12953 | Erythromycin Imp. E (EP): Erythromycin A Enol Ether | 含量测定 |
| MM0132.13 | 红霉素杂质B | 100mg | 26235 | Erythromycin Imp. B (EP): N-Demethylerythromycin A | 含量测定 |
| MM0133.00 | 阿司匹林 | 500mg | 12953 | Acetylsalicylic Acid | 含量测定 |
| MM0134.00 | 替利定盐酸盐半水合物 | 100mg | 12953 | Tilidine Hydrochloride Hemihydrate [Controlled Substance] | 含量测定 |
| MM0134.01 | 替利定盐酸盐半水合物杂质A | 100mg | 26235 | Tilidine Hydrochloride Hemihydrate Imp. A (EP): Ethyl (1RS,2RS)-2-(Dimethylamino)-1-phenylcyclohex-3-enecarboxylate (cis-Tilidine)[Controlled Substance] | 含量测定 |
| MM0134.03 | 替利定盐酸盐半水合物杂质D | 100mg | 12953 | Tilidine Hydrochloride Hemihydrate Imp. D (EP) as Hydrochloride: Ethyl (2RS)-3-Dimethylamino-2-phenylpropanoateHydrochloride | 含量测定 |
| MM0134.05 | 替利定 | 100mg | 12953 | Tilidine [Controlled Substance] | 含量测定 |
| MM0136.00 | 阿普唑仑 | 100mg | 12953 | Alprazolam [Controlled Substance] | 含量测定 |
| MM0137.00 | 蒽三酚 | 500mg | 12953 | Dithranol | 含量测定 |
| MM0137.01 | 蒽三酚杂质B | 100mg | 12953 | Dithranol Imp. B (EP): 1,8-Dihydroxyanthracene-9,10-dione (Danthron) | 含量测定 |
| MM0137.02 | 蒽三酚杂质C | 100mg | 12953 | Dithranol Imp. C (EP): 4,4,5,5-Tetrahydroxy-9,9-bianthracenyl-10,10(9H,9H)-dione(Dithranol Dimer) | 含量测定 |
| MM0137.04 | 蒽三酚杂质A | 100mg | 12953 | Dithranol Imp. A (EP): Anthracen-9(10H)-one (Anthrone) | 含量测定 |
| MM0138.04 | 氟哌利多杂质D | 100mg | 12953 | Droperidol Imp. D (EP) as Hydrochloride: (1RS)-1-[4-(4-Fluorophenyl)-4-oxobutyl]-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1,2,3,6-tetrahydropyridine 1-Oxide Hydrochloride | 含量测定 |
| MM0139.00 | 非洛地平 | 100mg | 12953 | Felodipine | 含量测定 |
| MM0139.01 | 非洛地平杂质A | 50mg | 26235 | Felodipine Imp.A ( EP) :Ethyl Methyl-4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate | 含量测定 |
| MM0139.02 | 非洛地平杂质B | 100mg | 12953 | Felodipine Imp. B (EP):Dimethyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 含量测定 |
| MM0139.03 | 非洛地平杂质C | 100mg | 12953 | Felodipine Imp.C ( EP) : Diethyl-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 含量测定 |
相关产品推荐
